Northeast
Israel appoints honorary consul in Northeast India
Our Reporter
Dimapur, Jan. 8 (EMN): Israel has appointed an honorary consul in the Northeast India as part of efforts to increase its presence and collaborations in the region. The honorary consul will be based in Assam.
The Embassy of Israel in India has appointed Joyshree Das Verma as honorary consul in the region with jurisdiction over the states of Assam, Arunachal Pradesh, Nagaland, Manipur, Mizoram, Meghalaya, Tripura and Sikkim, informed a statement issued by the Embassy.
“The relations between our two countries are growing and expanding rapidly. We are now going to take it forward and increase our presence in North-East India,” Ambassador of Israel in India, Ron Malka was quoted as saying by PTI while announcing the appointment.
“I am proud to present the credentials of Israeli honorary consul to Joyshree Das Verma who will work with us to further strengthen our growing partnership in this region,” he stated.
Verma said that she was honoured and humbled to represent Israel as honorary consul for the north-eastern states and stated: “This all-encompassing role excites me greatly as there are vast possibilities and opportunities to leverage Israel’s technology and expertise in various areas. I have pledged to work in the best interests of Assam and all North Eastern States.”
The Embassy aims to identify all possible areas of co-operation in the Northeast, where Israel can bring in its expertise and advanced technologies to benefit people in the region, the Embassy said.
In November 2020, Malka visited Assam, Meghalaya and Tripura and had official meetings with the chief ministers of the states. They discussed about collaboration on a range of subjects including agriculture, water management, tourism, horticulture, fisheries and dairy, the report stated.
During the visit, the ambassador laid the foundation stone of a Centre of Excellence (CoE) for Vegetables in Khetri, Assam. The region’s first Indo-Israeli Centre of Excellence was inaugurated in Mizoram in 2018, the report added.